Tirzepatide (20mg)
$75.00
Quantity
Summary: Dual GLP-1/GIP receptor agonist for glycemic control & weight loss.
Chemical Data:
Formula: C225H348N48O68
MW: 4813.45 g/mol
Purity: >99% (HPLC/MS)
CAS: 2023788-19-2
Key Studies:
NEJM (2021): 20.9% weight loss vs. 9.8% for semaglutide (PubMed)
JAMA (2022): Superior glycemic control, cardiovascular benefits (PubMed)
Mechanism: Amplifies insulin secretion (GIP) + delays gastric emptying (GLP-1).
Research Focus: Diabetes Management, Obesity Treatment, Cardiometabolic Health.